Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
Published Online: 2011-09-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Albert Hoenekopp•Andreas Hochhaus•Carmino De Souza•Gianantonio Rosti•Giuseppe Saglio•Hagop M Kantarjian•Hirohisa Nakamae•Ian W Flinn•Leif Stenke•Neil J Gallagher•Richard A Larson•Rick E Blakesley•Timothy P Hughes•Yeow-Tee Goh
